Box office is reclaiming pre-pandemic attendance—women and younger moviegoers are driving the swing

The clearest contradiction to the “trade-down” consumer narrative is showing up in theatrical admissions behavior—especially among younger audiences. In a Fandango survey of 7,000 adults, 87% of Gen Z and 82% of millennials reported seeing a movie in theaters in the past 12 months, versus 70% for Gen X and 58% for baby boomers. Put differently: the post-pandemic recovery is no longer only about price; it’s also about who’s choosing the theater.

The recovery isn’t uniform across metrics. According to S&P Global figures cited by NPR, through mid-August the year before the pandemic, U.S. cinemas sold 795.9 million tickets; through mid-August in 2026, ticket sales were 547.1 million—about 248.8 million fewer admissions. The bullish twist is that spend per attendance is stronger: NPR also reports that the average adult ticket price is above $13, with premium-format tickets running higher than standard formats (IMAX-style premium vs. standard).

Exhibitors sit in the middle of the theatrical supply chain: studios depend on opening-week attendance to set downstream expectations for holdovers and platform allocation, while exhibitors depend on early-ticket throughput to finance the next slate (and keep projection/audiovisual capex and staffing plans from being guesswork). If a “trade-down” consumer story dominates, studios struggle to sell broad audience demand; that pushes behavior toward niche, repeatable formats (or accelerated home/streaming diversion).

In 2026, the demographic profile changes that dynamic. Higher theater penetration among Gen Z and millennials supports broader opening-week turnout, while premium-format pricing supports revenue per patron even when admissions are still below 2019. That combination improves the probability that the theatrical window economics stabilize in a way retail-economy “bear” analogs would predict is impossible.

To translate the audience signal into investable outcomes, you want companies with (1) direct exposure to theatrical footfall, (2) pricing power via premium formats or ad inventory sold against screens, and/or (3) leverage to incremental ticket traffic without needing big balance-sheet expansion.

Short term (days to quarters): watch whether premium-format pricing remains elevated and whether younger demographics sustain attendance frequency through late summer and into fall. The market will interpret a sustained mix shift as evidence that exhibitors and format networks aren’t merely surviving on price.

Long term (1–3 years): the durable win is a return of studios’ confidence in theatrical openings that lead to healthier overall window economics. If the demographic recovery persists, studios may be more willing to fund theatrical-heavy slates and longer theatrical commitments—improving the odds that exhibitors convert incremental demand into improved leverage rather than only higher ticket prices.